Sarcopenia and Peripheral Artery Disease With Chronic Limb Threatening Ischemia

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

97 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-01-01

Study Completion Date

2024-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To evaluate the correlation of Sarcopenia Parameters and Peripheral Artery Disease with chronic limb threatening ischaemia.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Exercise Capability and Training Effects in Diabetic Patients With Neuropathy

NCT01760707

Diabetes Mellitus Peripheral Neuropathy

COMPLETED NA

Muscle and Bone in Patients with Diabetes Mellitus and Neuropathy

NCT06519942

Diabetes Mellitus, Type 2 Diabetic Peripheral Neuropathy Sarcopenia

RECRUITING

Association Between Sarcopenia And Diabetic Neuropathy In Adults With Type 1 Diabetes, A Pilot Study

NCT06902597

Type 1 Diabetes

RECRUITING NA

Sensorimotor Training and Gait in Diabetic Polyneuropathy

NCT04543032

Diabetic Peripheral Neuropathy

COMPLETED NA

Effects of Foot Muscle Strengthening in Daily Activity in Diabetic Neuropathic Patients

NCT02790931

Diabetic Neuropathies

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Prior researches indicated a relatively high prevalence of sarcopenia among patients of Peripheral Artery Disease. However, the relationship between sarcopenia and progression of Peripheral Artery Disease with chronic limb threatening ischaemia remained poorly understood. Thus, this cohort study aimed to evaluate the correlation of Sarcopenia Parameters, such as psoas muscle area (PMA) and total abdominal muscle area (TAMA) at the L3 vertebral level, measured by computed tomography (CT), and progression of Peripheral Artery Disease with chronic limb threatening ischaemia.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sarcopenia Peripheral Arterial Disease Chronic Limb Threatening Ischemia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

patiets with peripheral artery disease

Not applicable- observational study

Intervention Type OTHER

non-applicable

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Not applicable- observational study

non-applicable

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients of Peripheral Artery Disease, including intermittent claudication and Chronic Limb Threatening Ischemia;
* Patients with Rutherford grade 2-6 between Jan.1 2023 and Dec.31 2024;
* Patients at age 18-80;
* Patients underwent an in-hospital routine enhanced whole abdomen to lower extremities CT scan;
* Patients able to complete the clinical follow-up for 3 months.